Michel Evaux

Michel Evaux serves as CEO of RAFFIN MEDICAL at Raffin Medical. Raffin Medical operates in the medical devices sector with approximately 89.0 employees. The company is headquartered in Lyon, Auvergne-Rhone-Alpes.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 490 executive contacts are available in Auvergne-Rhone-Alpes.
• • Our database includes 201,469 c suite-level executives.

MailJet Outlook Pardot Microsoft Office 365 WordPress.org Mobile Friendly Nginx Shutterstock Facebook Widget Facebook Login (Connect) Google Font API AI

dispositifs medicaux a usage unique & sets et packs sets et packs dispositifs medicaux a usage unique medical equipment manufacturing single-use custom kits surgical packs sterile sets bandages swabs wound care hygiene products protective equipment home care hospital supplies healthcare solutions patient care instrumentation care sets absorption products compresses personalized medical solutions environmental responsibility iso certified customer satisfaction global distribution manufacturing innovation csr commitment medical technology supply chain management disposable products healthcare professionals clinical kits anesthesia sets dialysis packs obstetric packs personal protective equipment safety gear quality assurance patient safety medical packaging gowns gloves masks surgical instruments critical care supplies healthcare logistics product customization sustainability initiatives market leadership social responsibility partner networks medical devices hospital & health care logistics & supply chain

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Michel Evaux in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Raffin Medical.

Michel Evaux's Position in the MessageCEO Database

• •Michel Evaux is 1 of 1 verified executive contact we track at Raffin Medical.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •487 verified executive contacts in Auvergne-Rhone-Alpes are in the database.
• •3 verified contacts work at medical devices companies in the 89.0 employee range (same size as Raffin Medical).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Michel Evaux directly?

Michel Evaux's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO of RAFFIN MEDICAL at Raffin Medical. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Michel Evaux work for?

Michel Evaux is CEO of RAFFIN MEDICAL at Raffin Medical, a company in the medical devices sector with 89.0 employees. The company is based in Lyon, Auvergne-Rhone-Alpes.

Can I pitch or sell to Michel Evaux?

As CEO of RAFFIN MEDICAL at Raffin Medical, Michel Evaux is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Michel Evaux directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Michel Evaux in?

Michel Evaux works in the medical devices industry as CEO of RAFFIN MEDICAL at Raffin Medical. MessageCEO provides verified contact information for executives across all major industries.

Is Michel Evaux's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michel Evaux's profile is kept up-to-date with the latest available information.

Last updated: July 19, 2026